Fadogia Agrestis
Research reviewed: up until 03/2023
Fadogia Agrestis (Fadogia agrestis) is a dietary supplement with 2 published peer-reviewed studies involving 0 participants, researched for General.
Evidence at a Glance
Strength is scored by study design, sample size, study type, and outcomes
General
WeakResearch Visualised
Visual breakdown of the clinical data.
Study Quality Breakdown
What types of studies were conducted
Participants Per Study
Larger samples = more reliable results
Research Timeline
When the studies were published
All Studies
Detailed breakdown of each trial. Click to expand.
General
Animal study (rats) Study length: 5 days
Study Type
Animal study (rats) Study length: 5 days
Results
The various doses of Fadogia agrestis (18 mg/kg, 50 mg/kg and 100 mg/kg) produced two-, three- and six-fold increases in blood testosterone compared with the control. All doses of Fadogia agrestis significantly prolonged the ejaculatory latency and improved markers of libido. It increased mount and intromission frequency (higher intercourse frequency) and reduced mount and intromission latency (reduced time before intercourse). Conclusion: All doses of Fadogia agrestis increased testosterone levels, delayed ejaculation, increased intercourse frequency and improved markers of libido. 100 mg/kg of Fadogia agrestis increased blood testosterone levels by 600%.
Animal study (rats)
Study Type
Animal study (rats)
Results
Fadogia agrestis restored the NO/cGMP pathway (a mediator of erections) and key enzymes in the penile and testicular tissues of male rats. Conclusion: Fadogia agrestis may help improve erectile dysfunction.
Frequently Asked Questions
Common questions about Fadogia Agrestis research
There are currently 2 peer-reviewed studies on Fadogia Agrestis (Fadogia agrestis), involving 0 total participants. Research covers General. The overall evidence strength is rated as Weak.
The evidence is currently rated as "Weak Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (0 human studies, 2 animal studies), and reported outcomes.
Fadogia Agrestis has been researched for: General. Each area has its own body of evidence which you can explore in the study breakdowns above.
Currently all 2 studies on Fadogia Agrestis are animal or in-vitro studies. Human clinical trials are needed before the evidence can be rated above "Weak".
